http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001518476-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate | 1998-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001518476-A |
| titleOfInvention | 3'-N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity |
| abstract | (57) Abstract: A novel 3′-N-modified 6-O-substituted erythromycin ketolide compound having formula (I), (II), (III), (IV) or (V) having antibacterial activity, Pharmaceutically acceptable salts and esters, a composition comprising a therapeutically effective amount of a compound of the present invention together with a pharmaceutically acceptable carrier, and a pharmaceutical composition comprising a therapeutically effective amount of a compound of the present invention in a mammal. A method of treating a bacterial infection by administering. Embedded image |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008508322-A |
| priorityDate | 1997-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 458.